Related Experiment Video
Updated: May 23, 2026
07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Protein quality control in neurodegenerative disease
1Department of Pathology and the Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA.
Progress in Molecular Biology and Translational Science
|April 10, 2012
Summary
Misfolded proteins accumulate in neurodegenerative diseases, suggesting a link to cellular protein quality control. This system, which degrades damaged proteins, declines with age and may be crucial for preventing these conditions.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Accumulation of misfolded proteins is a hallmark of neurodegenerative diseases.
- Cellular protein quality control (PQC) pathways manage protein homeostasis.
- PQC components, like molecular chaperones, show protective effects in disease models.
Purpose of the Study:
- To explore the link between neurodegeneration and PQC.
- To present current models of PQC dysfunction in disease.
- To discuss challenges in maintaining PQC for specific proteins.
Main Methods:
- Review of existing scientific literature.
- Analysis of evidence connecting PQC to neurodegenerative disorders.
- Discussion of age-related decline in PQC.
Main Results:
- Strong correlation observed between misfolded protein aggregation and neurodegeneration.
- Evidence suggests PQC activation is protective against neurodegeneration.
- PQC efficiency appears to decrease with aging.
Conclusions:
- PQC dysfunction is a significant factor in neurodegenerative diseases.
- Age-related PQC decline exacerbates neurodegeneration.
- Understanding PQC failures is key to developing therapeutic strategies.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Protein Folding Quality Check in the RER
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...